[HTML][HTML] Role of peroxisome proliferators-activated receptors in the pathogenesis and treatment of nonalcoholic fatty liver disease
ER Kallwitz, A McLachlan, SJ Cotler - World journal of …, 2008 - ncbi.nlm.nih.gov
Nonalcoholic fatty liver disease (NAFLD) is highly prevalent and can result in nonalcoholic
steatohepatitis (NASH) and progressive liver disease including cirrhosis and hepatocellular …
steatohepatitis (NASH) and progressive liver disease including cirrhosis and hepatocellular …
[引用][C] Role of peroxisome proliferators-activated receptors in the pathogenesis and treatment of nonalcoholic fatty liver disease
ER KALLWITZ - World J. Gastroenterol., 2008 - cir.nii.ac.jp
Role of peroxisome proliferators-activated receptors in the pathogenesis and treatment of
nonalcoholic fatty liver disease | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ …
nonalcoholic fatty liver disease | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ …
[HTML][HTML] Role of peroxisome proliferators-activated receptors in the pathogenesis and treatment of nonalcoholic fatty liver disease
ER Kallwitz, A McLachlan, SJ Cotler - World Journal of …, 2008 - wjgnet.com
Nonalcoholic fatty liver disease (NAFLD) is highly prevalent and can result in nonalcoholic
steatohepatitis (NASH) and progressive liver disease including cirrhosis and hepatocellular …
steatohepatitis (NASH) and progressive liver disease including cirrhosis and hepatocellular …
Role of peroxisome proliferators-activated receptors in the pathogenesis and treatment of nonalcoholic fatty liver disease
ER Kallwitz, A McLachlan… - World journal of …, 2008 - pubmed.ncbi.nlm.nih.gov
Nonalcoholic fatty liver disease (NAFLD) is highly prevalent and can result in nonalcoholic
steatohepatitis (NASH) and progressive liver disease including cirrhosis and hepatocellular …
steatohepatitis (NASH) and progressive liver disease including cirrhosis and hepatocellular …
Role of peroxisome proliferators-activated receptors in the pathogenesis and treatment of nonalcoholic fatty liver disease.
ER Kallwitz, A McLachlan, SJ Cotler - World Journal of …, 2008 - europepmc.org
Nonalcoholic fatty liver disease (NAFLD) is highly prevalent and can result in nonalcoholic
steatohepatitis (NASH) and progressive liver disease including cirrhosis and hepatocellular …
steatohepatitis (NASH) and progressive liver disease including cirrhosis and hepatocellular …
[PDF][PDF] Role of peroxisome proliferators-activated receptors in the pathogenesis and treatment of nonalcoholic fatty liver disease
ER Kallwitz, A McLachlan, SJ Cotler - World J Gastroenterol, 2008 - researchgate.net
Nonalcoholic fatty liver disease (NAFLD) is highly prevalent and can result in nonalcoholic
steatohepatitis (NASH) and progressive liver disease including cirrhosis and hepatocellular …
steatohepatitis (NASH) and progressive liver disease including cirrhosis and hepatocellular …
[PDF][PDF] Role of peroxisome proliferators-activated receptors in the pathogenesis and treatment of nonalcoholic fatty liver disease
ER Kallwitz, A McLachlan, SJ Cotler - World J Gastroenterol, 2008 - Citeseer
Nonalcoholic fatty liver disease (NAFLD) is highly prevalent and can result in nonalcoholic
steatohepatitis (NASH) and progressive liver disease including cirrhosis and hepatocellular …
steatohepatitis (NASH) and progressive liver disease including cirrhosis and hepatocellular …
[引用][C] Role of peroxisome proliferators-activated receptors in the pathogenesis and treatment of nonalcoholic fatty liver disease
ER Kallwitz, A McLachlan, SJ Cotler - World Journal of Gastroenterology, 2008 - cir.nii.ac.jp
Role of peroxisome proliferators-activated receptors in the pathogenesis and treatment of
nonalcoholic fatty liver disease | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ …
nonalcoholic fatty liver disease | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ …
Role of peroxisome proliferators-activated receptors in the pathogenesis and treatment of nonalcoholic fatty liver disease
ER Kallwitz, A McLachlan, SJ Cotler - World Journal of …, 2008 - wjgnet.com
Figure 2 Mechanisms by which PPARs and their ligands can modulate triglyceride
accumulation are highlighted by letters in the figure. A: PPARγ increases expression of …
accumulation are highlighted by letters in the figure. A: PPARγ increases expression of …
Role of peroxisome proliferators-activated receptors in the pathogenesis and treatment of nonalcoholic fatty liver disease.
ER Kallwitz, A McLachlan, SJ Cotler - World Journal of …, 2008 - europepmc.org
Nonalcoholic fatty liver disease (NAFLD) is highly prevalent and can result in nonalcoholic
steatohepatitis (NASH) and progressive liver disease including cirrhosis and hepatocellular …
steatohepatitis (NASH) and progressive liver disease including cirrhosis and hepatocellular …